Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-label Randomized Controlled Trial of Oral Transmucosal Haloperidol and Olanzapine in the Treatment of Terminal Delirium

NCT04750395 is registered in ClinicalTrials.gov with HCA Hospice Care as lead sponsor.

NCT NCT04750395
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04750395 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-label Randomized Controlled Trial of Oral Transmucosal Haloperidol and Olanzapine in the Treatment of Terminal Delirium
Lead sponsor
HCA Hospice Care
Phase
Phase 2
Overall status
Unknown status
Start date
September 1, 2021
Completion date
May 31, 2024
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

delirium, terminal illness